» Authors » Akitomo Narimatsu

Akitomo Narimatsu

Explore the profile of Akitomo Narimatsu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 18
Citations 77
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Narimatsu A, Singh R, Surico P, Lee S, Forouzanfar K, Kahale F, et al.
J Clin Med . 2024 Sep; 13(17). PMID: 39274223
: In this study, we establish a protocol for evaluating the outcomes of endothelial keratoplasty, including graft survival, rejection, or failure. Additionally, we also evaluate the alloimmune response in graft...
2.
Blanco T, Nakagawa H, Musayeva A, Krauthammer M, Singh R, Narimatsu A, et al.
JCI Insight . 2024 Sep; 9(20). PMID: 39235864
After transplantation, Th1-mediated immune rejection is the predominant cause of graft failure. Th1 cell sensitization occurs through complex and context-dependent interaction among antigen-presenting cell subsets, particularly CD11b+ DCs (DC2) and...
3.
Surico P, Narimatsu A, Forouzanfar K, Singh R, Shoushtari S, Dana R, et al.
Cells . 2024 Mar; 13(6. PMID: 38534376
Diabetes mellitus (DM) is one of the most prevalent diseases globally, and its prevalence is rapidly increasing. Most patients with a long-term history of DM present with some degree of...
4.
Lee S, Blanco T, Musayeva A, Dehghani S, Narimatsu A, Forouzanfar K, et al.
Am J Transplant . 2024 Mar; 24(9):1597-1609. PMID: 38514014
Highly inflamed and neovascularized corneal graft beds are known as high-risk (HR) environments for transplant survival. One of the primary factors leading to this rejection is reduction in the suppressive...
5.
Alemi H, Dehghani S, Forouzanfar K, Surico P, Narimatsu A, Musayeva A, et al.
Exp Eye Res . 2023 Sep; 236:109657. PMID: 37722586
Exposure to mustard agents, such as sulfur mustard (SM) and nitrogen mustard (NM), often results in ocular surface damage. This can lead to the emergence of various corneal disorders that...
6.
Alemi H, Dehghani S, Musayeva A, Nadari A, Narimatsu A, Sharifi S, et al.
Exp Eye Res . 2023 May; :109495. PMID: 37142048
Exposure to mustard agents, such as sulfur mustard (SM) and nitrogen mustard (NM), often results in ocular surface damage. This can lead to the emergence of various corneal disorders that...
7.
Noma H, Yasuda K, Narimatsu A, Asakage M, Shimura M
Sci Rep . 2023 Jan; 13(1):1536. PMID: 36707696
We evaluated the long-term (24-month) efficacy of a novel individualized treatment protocol with 2 mg aflibercept for treatment-naive BRVO with macular edema. Each patient received an initial aflibercept injection and...
8.
Otawa T, Noma H, Yasuda K, Narimatsu A, Asakage M, Tanaka A, et al.
BMC Ophthalmol . 2022 Jun; 22(1):247. PMID: 35658906
Background: Patients with central retinal vein occlusion (CRVO) and macular edema often are treated by intravitreal ranibizumab injection (IRI). The role of changes in macular sensitivity in the positive effects...
9.
Nezu N, Usui Y, Saito A, Shimizu H, Asakage M, Yamakawa N, et al.
Ophthalmology . 2021 Jan; 128(8):1197-1208. PMID: 33484732
Purpose: Various immune mediators have crucial roles in the pathogenesis of intraocular diseases. Machine learning can be used to automatically select and weigh various predictors to develop models maximizing predictive...
10.
Narimatsu A, Hattori T, Usui Y, Ueno H, Funaki T, Komatsu H, et al.
Exp Eye Res . 2020 Aug; 199:108190. PMID: 32798537
Purpose: To determine whether the CD27/CD70 pathway plays a significant role in corneal allograft rejection by investigating the effect of blocking the CD27/CD70 pathway by anti-CD70 antibody on corneal allograft...